Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Almirall
Biotech
Almirall signs yes-nonsense deal with Eloxx for $3M upfront
Almirall is handing over $3 million for Eloxx Pharmaceuticals’ molecule for a pair of rare skin diseases just before the drug enters the clinic.
James Waldron
Mar 13, 2024 10:31am
Almirall signs $210M deal with EpimAb to develop bispecifics
Oct 12, 2023 9:55am
New CEO will lead Teva at top of new year—Chutes & Ladders
Dec 2, 2022 9:30am
Almirall signs on with clinical trial project to collect data
Nov 29, 2022 10:32am
Lilly's would-be Dupixent rival scores another late-stage win
Dec 21, 2021 7:55am
Almirall taps Iktos for AI drug discovery work
Dec 12, 2019 11:10am
